Loading…

CYC1 Predicts Poor Prognosis in Patients with Breast Cancer

Cytochrome c-1 (CYC1) is an important subunit of mitochondrial complex III. However, its role in tumor progression is unclear. We found that CYC1 was upregulated in breast tumor tissues, especially in tissues with lymph node metastasis. And higher expression of CYC1 correlates with poor prognosis in...

Full description

Saved in:
Bibliographic Details
Published in:Disease markers 2016-01, Vol.2016 (2016), p.1-9
Main Authors: Gao, Qinglei, Wu, Peng, Ma, Ding, Liu, Jia, Gao, Peipei, Gong, Song, Zhang, Zeyu, Zhao, Meisong, Sun, Shujuan, Han, Yingyan, Zhou, Jianfeng
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3
cites cdi_FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3
container_end_page 9
container_issue 2016
container_start_page 1
container_title Disease markers
container_volume 2016
creator Gao, Qinglei
Wu, Peng
Ma, Ding
Liu, Jia
Gao, Peipei
Gong, Song
Zhang, Zeyu
Zhao, Meisong
Sun, Shujuan
Han, Yingyan
Zhou, Jianfeng
description Cytochrome c-1 (CYC1) is an important subunit of mitochondrial complex III. However, its role in tumor progression is unclear. We found that CYC1 was upregulated in breast tumor tissues, especially in tissues with lymph node metastasis. And higher expression of CYC1 correlates with poor prognosis in breast cancer patients using online databases and tools. Then we confirmed that CYC1 contributed to metastasis and proliferation in two highly metastatic human breast cancer cell lines. Digging into the biological function of CYC1, we found the activity of mitochondrial complex III decreased due to silencing CYC1. Then the ratio of AMP to ATP increased and AMPK was activated. Analyzing units of other mitochondrial complexes, we did not find knockdown of CYC1 expression reduced expression of any other unit of OXPHOS. We concluded that CYC1 promoted tumor metastasis via suppressing activation of AMPK and contributed to tumor growth via facilitating production of ATP. Our results indicated that CYC1 plays crucial roles in breast cancer progression and might be a predictive factor assisting future patient diagnosis.
doi_str_mv 10.1155/2016/3528064
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4864557</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A508841399</galeid><sourcerecordid>A508841399</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3</originalsourceid><addsrcrecordid>eNqNkUtrGzEURkVISZy0u6zDQDeFdGpdvUWgkAx9QaBetIuuhEajsVXGo0QaJ_TfV8au2-6CFkLcw-G7-hC6APwOgPM5wSDmlBOFBTtCM1CS10pQfIxmmEhVY8LwKTrL-SfGQDTTJ-iUSEI1VmqGrpsfDVSL5LvgplwtYkzlFZdjzCFXYawWdgp-LKOnMK2q2-RtnqrGjs6nl-hFb4fsX-3vc_T944dvzef67uunL83NXe2YhKlWvXDWa-awklqVU3IwR4RSLZUguYbOKecka3nPpbKSW8m4E7ztAVrc0XP0fue937Rr37kSJ9nB3KewtumXiTaY_ydjWJllfDRMCca5LII3e0GKDxufJ7MO2flhsKOPm2xAakpAcMEK-nqHLu3gTRj7WIxui5sbXn6MAdW6UG93lEsx5-T7QxjAZtuK2bZi9q0U_PLfBQ7wnxoKcLUDVmHs7FN4ps4Xxvf2Lw2YCsXpb-UKm98</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1793216564</pqid></control><display><type>article</type><title>CYC1 Predicts Poor Prognosis in Patients with Breast Cancer</title><source>Wiley_OA刊</source><creator>Gao, Qinglei ; Wu, Peng ; Ma, Ding ; Liu, Jia ; Gao, Peipei ; Gong, Song ; Zhang, Zeyu ; Zhao, Meisong ; Sun, Shujuan ; Han, Yingyan ; Zhou, Jianfeng</creator><contributor>Liotta, Lance A.</contributor><creatorcontrib>Gao, Qinglei ; Wu, Peng ; Ma, Ding ; Liu, Jia ; Gao, Peipei ; Gong, Song ; Zhang, Zeyu ; Zhao, Meisong ; Sun, Shujuan ; Han, Yingyan ; Zhou, Jianfeng ; Liotta, Lance A.</creatorcontrib><description>Cytochrome c-1 (CYC1) is an important subunit of mitochondrial complex III. However, its role in tumor progression is unclear. We found that CYC1 was upregulated in breast tumor tissues, especially in tissues with lymph node metastasis. And higher expression of CYC1 correlates with poor prognosis in breast cancer patients using online databases and tools. Then we confirmed that CYC1 contributed to metastasis and proliferation in two highly metastatic human breast cancer cell lines. Digging into the biological function of CYC1, we found the activity of mitochondrial complex III decreased due to silencing CYC1. Then the ratio of AMP to ATP increased and AMPK was activated. Analyzing units of other mitochondrial complexes, we did not find knockdown of CYC1 expression reduced expression of any other unit of OXPHOS. We concluded that CYC1 promoted tumor metastasis via suppressing activation of AMPK and contributed to tumor growth via facilitating production of ATP. Our results indicated that CYC1 plays crucial roles in breast cancer progression and might be a predictive factor assisting future patient diagnosis.</description><identifier>ISSN: 0278-0240</identifier><identifier>EISSN: 1875-8630</identifier><identifier>DOI: 10.1155/2016/3528064</identifier><identifier>PMID: 27239088</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Adenosine Triphosphate - metabolism ; Adult ; AMP-Activated Protein Kinases - metabolism ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Breast cancer ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Cancer patients ; Carcinoma, Ductal - metabolism ; Carcinoma, Ductal - pathology ; Cell Line, Tumor ; Cell Proliferation ; Cytochrome b ; Cytochromes c1 - genetics ; Cytochromes c1 - metabolism ; Development and progression ; Female ; Humans ; Medical research ; Medicine, Experimental ; Metastasis ; Middle Aged ; Neoplasm Metastasis ; Online databases ; Oxidative Phosphorylation ; Prognosis</subject><ispartof>Disease markers, 2016-01, Vol.2016 (2016), p.1-9</ispartof><rights>Copyright © 2016 Yingyan Han et al.</rights><rights>COPYRIGHT 2016 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2016 Yingyan Han et al. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3</citedby><cites>FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27239088$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Liotta, Lance A.</contributor><creatorcontrib>Gao, Qinglei</creatorcontrib><creatorcontrib>Wu, Peng</creatorcontrib><creatorcontrib>Ma, Ding</creatorcontrib><creatorcontrib>Liu, Jia</creatorcontrib><creatorcontrib>Gao, Peipei</creatorcontrib><creatorcontrib>Gong, Song</creatorcontrib><creatorcontrib>Zhang, Zeyu</creatorcontrib><creatorcontrib>Zhao, Meisong</creatorcontrib><creatorcontrib>Sun, Shujuan</creatorcontrib><creatorcontrib>Han, Yingyan</creatorcontrib><creatorcontrib>Zhou, Jianfeng</creatorcontrib><title>CYC1 Predicts Poor Prognosis in Patients with Breast Cancer</title><title>Disease markers</title><addtitle>Dis Markers</addtitle><description>Cytochrome c-1 (CYC1) is an important subunit of mitochondrial complex III. However, its role in tumor progression is unclear. We found that CYC1 was upregulated in breast tumor tissues, especially in tissues with lymph node metastasis. And higher expression of CYC1 correlates with poor prognosis in breast cancer patients using online databases and tools. Then we confirmed that CYC1 contributed to metastasis and proliferation in two highly metastatic human breast cancer cell lines. Digging into the biological function of CYC1, we found the activity of mitochondrial complex III decreased due to silencing CYC1. Then the ratio of AMP to ATP increased and AMPK was activated. Analyzing units of other mitochondrial complexes, we did not find knockdown of CYC1 expression reduced expression of any other unit of OXPHOS. We concluded that CYC1 promoted tumor metastasis via suppressing activation of AMPK and contributed to tumor growth via facilitating production of ATP. Our results indicated that CYC1 plays crucial roles in breast cancer progression and might be a predictive factor assisting future patient diagnosis.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Adult</subject><subject>AMP-Activated Protein Kinases - metabolism</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Cancer patients</subject><subject>Carcinoma, Ductal - metabolism</subject><subject>Carcinoma, Ductal - pathology</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Cytochrome b</subject><subject>Cytochromes c1 - genetics</subject><subject>Cytochromes c1 - metabolism</subject><subject>Development and progression</subject><subject>Female</subject><subject>Humans</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Neoplasm Metastasis</subject><subject>Online databases</subject><subject>Oxidative Phosphorylation</subject><subject>Prognosis</subject><issn>0278-0240</issn><issn>1875-8630</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkUtrGzEURkVISZy0u6zDQDeFdGpdvUWgkAx9QaBetIuuhEajsVXGo0QaJ_TfV8au2-6CFkLcw-G7-hC6APwOgPM5wSDmlBOFBTtCM1CS10pQfIxmmEhVY8LwKTrL-SfGQDTTJ-iUSEI1VmqGrpsfDVSL5LvgplwtYkzlFZdjzCFXYawWdgp-LKOnMK2q2-RtnqrGjs6nl-hFb4fsX-3vc_T944dvzef67uunL83NXe2YhKlWvXDWa-awklqVU3IwR4RSLZUguYbOKecka3nPpbKSW8m4E7ztAVrc0XP0fue937Rr37kSJ9nB3KewtumXiTaY_ydjWJllfDRMCca5LII3e0GKDxufJ7MO2flhsKOPm2xAakpAcMEK-nqHLu3gTRj7WIxui5sbXn6MAdW6UG93lEsx5-T7QxjAZtuK2bZi9q0U_PLfBQ7wnxoKcLUDVmHs7FN4ps4Xxvf2Lw2YCsXpb-UKm98</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Gao, Qinglei</creator><creator>Wu, Peng</creator><creator>Ma, Ding</creator><creator>Liu, Jia</creator><creator>Gao, Peipei</creator><creator>Gong, Song</creator><creator>Zhang, Zeyu</creator><creator>Zhao, Meisong</creator><creator>Sun, Shujuan</creator><creator>Han, Yingyan</creator><creator>Zhou, Jianfeng</creator><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160101</creationdate><title>CYC1 Predicts Poor Prognosis in Patients with Breast Cancer</title><author>Gao, Qinglei ; Wu, Peng ; Ma, Ding ; Liu, Jia ; Gao, Peipei ; Gong, Song ; Zhang, Zeyu ; Zhao, Meisong ; Sun, Shujuan ; Han, Yingyan ; Zhou, Jianfeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Adult</topic><topic>AMP-Activated Protein Kinases - metabolism</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Cancer patients</topic><topic>Carcinoma, Ductal - metabolism</topic><topic>Carcinoma, Ductal - pathology</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Cytochrome b</topic><topic>Cytochromes c1 - genetics</topic><topic>Cytochromes c1 - metabolism</topic><topic>Development and progression</topic><topic>Female</topic><topic>Humans</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Neoplasm Metastasis</topic><topic>Online databases</topic><topic>Oxidative Phosphorylation</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gao, Qinglei</creatorcontrib><creatorcontrib>Wu, Peng</creatorcontrib><creatorcontrib>Ma, Ding</creatorcontrib><creatorcontrib>Liu, Jia</creatorcontrib><creatorcontrib>Gao, Peipei</creatorcontrib><creatorcontrib>Gong, Song</creatorcontrib><creatorcontrib>Zhang, Zeyu</creatorcontrib><creatorcontrib>Zhao, Meisong</creatorcontrib><creatorcontrib>Sun, Shujuan</creatorcontrib><creatorcontrib>Han, Yingyan</creatorcontrib><creatorcontrib>Zhou, Jianfeng</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Disease markers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gao, Qinglei</au><au>Wu, Peng</au><au>Ma, Ding</au><au>Liu, Jia</au><au>Gao, Peipei</au><au>Gong, Song</au><au>Zhang, Zeyu</au><au>Zhao, Meisong</au><au>Sun, Shujuan</au><au>Han, Yingyan</au><au>Zhou, Jianfeng</au><au>Liotta, Lance A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CYC1 Predicts Poor Prognosis in Patients with Breast Cancer</atitle><jtitle>Disease markers</jtitle><addtitle>Dis Markers</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>2016</volume><issue>2016</issue><spage>1</spage><epage>9</epage><pages>1-9</pages><issn>0278-0240</issn><eissn>1875-8630</eissn><abstract>Cytochrome c-1 (CYC1) is an important subunit of mitochondrial complex III. However, its role in tumor progression is unclear. We found that CYC1 was upregulated in breast tumor tissues, especially in tissues with lymph node metastasis. And higher expression of CYC1 correlates with poor prognosis in breast cancer patients using online databases and tools. Then we confirmed that CYC1 contributed to metastasis and proliferation in two highly metastatic human breast cancer cell lines. Digging into the biological function of CYC1, we found the activity of mitochondrial complex III decreased due to silencing CYC1. Then the ratio of AMP to ATP increased and AMPK was activated. Analyzing units of other mitochondrial complexes, we did not find knockdown of CYC1 expression reduced expression of any other unit of OXPHOS. We concluded that CYC1 promoted tumor metastasis via suppressing activation of AMPK and contributed to tumor growth via facilitating production of ATP. Our results indicated that CYC1 plays crucial roles in breast cancer progression and might be a predictive factor assisting future patient diagnosis.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>27239088</pmid><doi>10.1155/2016/3528064</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0278-0240
ispartof Disease markers, 2016-01, Vol.2016 (2016), p.1-9
issn 0278-0240
1875-8630
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4864557
source Wiley_OA刊
subjects Adenosine Triphosphate - metabolism
Adult
AMP-Activated Protein Kinases - metabolism
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Breast cancer
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Cancer patients
Carcinoma, Ductal - metabolism
Carcinoma, Ductal - pathology
Cell Line, Tumor
Cell Proliferation
Cytochrome b
Cytochromes c1 - genetics
Cytochromes c1 - metabolism
Development and progression
Female
Humans
Medical research
Medicine, Experimental
Metastasis
Middle Aged
Neoplasm Metastasis
Online databases
Oxidative Phosphorylation
Prognosis
title CYC1 Predicts Poor Prognosis in Patients with Breast Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A36%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CYC1%20Predicts%20Poor%20Prognosis%20in%20Patients%20with%20Breast%20Cancer&rft.jtitle=Disease%20markers&rft.au=Gao,%20Qinglei&rft.date=2016-01-01&rft.volume=2016&rft.issue=2016&rft.spage=1&rft.epage=9&rft.pages=1-9&rft.issn=0278-0240&rft.eissn=1875-8630&rft_id=info:doi/10.1155/2016/3528064&rft_dat=%3Cgale_pubme%3EA508841399%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c471t-8f6cae94c087989890014c2688b3717591dc8cc74b5f578a75a745c65bf11b0d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1793216564&rft_id=info:pmid/27239088&rft_galeid=A508841399&rfr_iscdi=true